Company intelligence / Profile preview
Advicenne
Paris, Franceadvicenne.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Advicenne's lead product Sibnayal® (ADV7103, a combination of potassium citrate and potassium bicarbonate) received approval from the European Medicine Agency and MHRA in 2021 for the treatment of distal Renal Tubular Acidosis (dRTA). The product is currently in Phase III development in the United States for dRTA and is also under development for cystinuria in both Europe and the United States. The FDA has granted Orphan Drug Designation to ADV7103 for both dRTA and cystinuria in the US.
- Therapeutic areas
- Rare DiseasesNephrology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Avanzanite Bioscience (for commercialization in Germany, Austria, Switzerland, Greece, and other European countries)Primex Pharmaceuticals AGSPA (for marketing in Italy, Spain, and Portugal)
Beyond the preview
Go deeper on Advicenne.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advicenne.